Kyntra Bio, Inc.
KYNBNasdaqCIK 921299HealthcareFiscal year ends Dec 31
Reports and events: 246 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:05 ET | 8-K | 3.01 Delisting notice | 0001193125-26-415545 |
| 2026-10-0111:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-409819 |
| 2026-08-3121:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-377059 |
| 2026-08-1320:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349183 |
| 2026-08-1320:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349141 |
| 2026-06-1623:23 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-271449 |
| 2026-06-0921:04 ET | 8-K | 8.01 Other events | 0001193125-26-264000 |
| 2026-05-1220:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219374 |
| 2026-05-1120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216731 |
| 2026-04-2720:06 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0001193125-26-182044 |
| 2026-04-0920:10 ET | 8-K | 3.01 Delisting notice | 0001193125-26-149624 |
| 2026-03-1620:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-108346 |
| 2026-03-1620:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-108324 |
| 2026-01-0721:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006327 |
| 2025-11-1021:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274241 |
| 2025-11-1021:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274192 |
| 2025-11-0621:11 ET | 8-K | 8.01 Other events | 0001193125-25-269529 |
| 2025-09-0521:04 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000921299-25-000007 |
| 2025-09-0212:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112341 |
| 2025-08-1812:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-109571 |
| 2025-08-1423:53 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-108280 |
| 2025-08-1120:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106549 |
| 2025-08-1120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106534 |
| 2025-07-1421:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-095628 |
| 2025-06-1320:05 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-25-086142 |
| 2025-06-1220:27 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-085439 |
| 2025-06-0920:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-083676 |
| 2025-05-1220:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069203 |
| 2025-05-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069159 |
| 2025-04-2521:00 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0000950170-25-058841 |
| 2025-04-0421:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-051219 |
| 2025-03-3121:44 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-25-046978 |
| 2025-03-2821:20 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-25-046948 |
| 2025-03-1720:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040280 |
| 2025-03-1720:10 ET | 8-K | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-040248 |
| 2025-02-2422:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-033539 |
| 2025-02-2012:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-023729 |
| 2024-12-1614:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-136408 |
| 2024-11-1221:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125388 |
| 2024-11-1221:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125332 |
| 2024-10-0320:05 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-24-112331 |
| 2024-09-1620:05 ET | 8-K | 3.01 Delisting notice | 0000950170-24-106818 |
| 2024-09-1320:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-106359 |
| 2024-09-0620:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-104395 |
| 2024-08-0721:05 ET | 8-K | 2.05 Exit or disposal costs | 0000950170-24-092967 |
| 2024-08-0620:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091808 |
| 2024-08-0620:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091766 |
| 2024-06-2612:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-077616 |
| 2024-06-0720:12 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070636 |
| 2024-05-0620:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053554 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.